Drug
RVU120
RVU120 is a pharmaceutical drug with 5 clinical trials. Currently 4 active trials ongoing.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
4(80%)
Phase Distribution
Ph phase_1
1
20%
Ph phase_2
4
80%
Phase Distribution
1
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
4(80.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
5
all time
Status Distribution
Active(5)
Detailed Status
Active, not recruiting2
Recruiting2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
4
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 11 (20.0%)
Phase 24 (80.0%)
Trials by Status
active_not_recruiting240%
not_yet_recruiting120%
recruiting240%
Recent Activity
4 active trials
Showing 5 of 5
not_yet_recruitingphase_2
RVU120 Rollover Study
NCT06987058
recruitingphase_2
RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis
NCT06397313
active_not_recruitingphase_2
Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML
NCT06268574
recruitingphase_2
Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML
NCT06191263
active_not_recruitingphase_1
RVU120 (SEL120) in Patients with Relapse/Refractory Metastatic or Advanced Solid Tumors
NCT05052255
Clinical Trials (5)
Showing 5 of 5 trials
NCT06987058Phase 2
RVU120 Rollover Study
NCT06397313Phase 2
RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis
NCT06268574Phase 2
Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML
NCT06191263Phase 2
Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML
NCT05052255Phase 1
RVU120 (SEL120) in Patients with Relapse/Refractory Metastatic or Advanced Solid Tumors
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5